2021, ' Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study : a multicentre, prospective cohort study ', The Lancet Microbe . https://doi.org/10.1016/S2666-5247(21)00090-2 LANCET MICROBE The Lancet Microbe E365 E354 investigators, ISARICC & Dark, P 2021, ' Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. ', The Lancet. Microbe, vol. 2, no. 8, pp. e354-e365 . https://doi.org/10.1016/S2666-5247(21)00090-2 The Lancet. Microbe
Investigators, ISARICC & Dark, P 2021, ' Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. ', The Lancet. Respiratory medicine, vol. 9, no. 7, pp. 773-785 . https://doi.org/10.1016/S2213-2600(21)00175-2 2021, ' Changes in in-hospital mortality in the first wave of COVID-19 : a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(21)00175-2 The Lancet. Respiratory Medicine
LANCET RESPIRATORY MEDICINE The Lancet. Respiratory Medicine ISARIC4C Investigators 2021, ' Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK ', The Lancet. Respiratory medicine, vol. 9, no. 7, pp. 699-711 . https://doi.org/10.1016/S2213-2600(21)00013-8 2021, ' Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 : a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK ', The Lancet Respiratory Medicine, vol. 9, no. 7, pp. 699-711 . https://doi.org/10.1016/S2213-2600(21)00013-8
The Lancet. Rheumatology e506 e498 Investigators, ISARICC & Dark, P 2021, ' Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. ', The Lancet. Rheumatology, vol. 3, no. 7, pp. e498-e506 . https://doi.org/10.1016/S2665-9913(21)00104-1 2021, ' Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort : a matched, prospective cohort study ', The Lancet Rheumatology, vol. 3, no. 7, pp. e498-e506 . https://doi.org/10.1016/S2665-9913(21)00104-1, https://doi.org/10.1016/S2665-9913(21)00104-1 The Lancet Rheumatology
Gupta, RK, Harrison, EM, Ho, A, Docherty, AB, Knight, SR, van, S M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, TM, Investigators, ISARICC & Dark, P 2021, ' Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. ', The Lancet. Respiratory medicine . https://doi.org/10.1016/s2213-2600(20)30559-2 The Lancet. Respiratory Medicine The Lancet Respiratory Medicine Gupta, R K, Harrison, E M, Ho, A, Docherty, A B, Knight, S R, van Smeden, M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, T M, Dunning, J, Fairfield, C J, Gamble, C, Green, C A, Halpin, S, Hardwick, H E, Holden, K A, Horby, P W, Jackson, C, Mclean, K A, Merson, L, Nguyen-Van-Tam, J S, Norman, L, Olliaro, P L, Pritchard, M G, Russell, C D, Scott-Brown, J, Shaw, C A, Sheikh, A, Solomon, T, Sudlow, C, Swann, O V, Turtle, L, Openshaw, P J M, Baillie, J K, Semple, M G, Noursadeghi, M & The ISARIC4C Investigators, 2021, ' Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19 : a prospective cohort study ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(20)30559-2
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5
2020, ' Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease : An International Multicenter Study ', American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 12, pp. 1656-1665 . https://doi.org/10.1164/rccm.202007-2794OC Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona Drake, T M, Docherty, A B, Harrison, E M, Quint, J K, Adamali, H, Agnew, S, Babu, S, Barber, C M, Barratt, S, Bendstrup, E, Bianchi, S, Villegas, D C, Chaudhuri, N, Chua, F, Coker, R, Chang, W, Crawshaw, A, Crowley, L E, Dosanjh, D, Fiddler, C A, Forrest, I A, George, P M, Gibbons, M A, Groom, K, Haney, S, Hart, S P, Heiden, E, Henry, M, Ho, L P, Hoyles, R K, Hutchinson, J, Hurley, K, Jones, M, Jones, S, Kokosi, M, Kreuter, M, MacKay, L S, Mahendran, S, Margaritopoulos, G, Molina-Molina, M, Molyneaux, P L, O'Brien, A, O'Reilly, K, Packham, A, Parfrey, H, Poletti, V, Porter, J C, Renzoni, E, Rivera-Ortega, P & ISARIC4C Investigators 2020, ' Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study ', American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 12, pp. 1656-1665 . https://doi.org/10.1164/rccm.202007-2794OC Drake, TM, Docherty, AB, Harrison, EM, Quint, JK, Adamali, H, Agnew, S, Babu, S, Barber, CM, Barratt, S, Bendstrup, E, Bianchi, S, Castillo, V D, Investigators, ISARICC & Dark, P 2020, ' Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. ', American Journal of Respiratory and Critical Care Medicine . https://doi.org/10.1164/rccm.202007-2794oc, https://doi.org/10.1164/rccm.202007-2794oc American Journal of Respiratory and Critical Care Medicine